Trafficking of LAG-3 to the Surface on Activated T Cells via Its Cytoplasmic Domain and Protein Kinase C Signaling-Reference-Cited by-同舟云学术

Trafficking of LAG-3 to the Surface on Activated T Cells via Its Cytoplasmic Domain and Protein Kinase C Signaling

Published:2014-08-08 Issue:6 Volume:193 Page:3101-3112
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Bae Joonbeom,Lee Suk Jun,Park Chung-Gyu,Lee Young Sik,Chun Taehoon

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference32 articles.

1. LAG-3, a novel lymphocyte activation gene closely related to CD4.

2. Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens.

3. Proliferation of activated CD1d-restricted NKT cells is down-modulated by lymphocyte activation gene-3 signaling via cell cycle arrest in S phase

4. Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells

5. Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress of lymphocyte activation gene 3 and programmed cell death protein 1 antibodies for cancer treatment: A review;Biomolecules and Biomedicine;2024-04-06

2. Single-cell data revealed exhaustion of characteristic NK cell subpopulations and T cell subpopulations in hepatocellular carcinoma;Aging;2024-04-05

3. Other Immune Checkpoint Targets of Interest;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

4. Bibliometric analysis of evolutionary trajectory and prospective directions of LAG-3 in cancer;Frontiers in Immunology;2024-02-08

5. Lymphocyte-activation gene 3 (LAG-3) as a promising immune checkpoint in cancer immunotherapy: From biology to the clinic;Pathology - Research and Practice;2024-02